[1]
J. G. Piñeros, “Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia”, J Infect Dev Ctries, vol. 15, no. 11, pp. 1708-1713, Nov. 2021.